123 related articles for article (PubMed ID: 37867123)
1. [Long-term visual outcomes of Boston type I keratoprosthesis in Canada].
Aoun T; Harissi-Dagher M
J Fr Ophtalmol; 2023 Dec; 46(10):1212-1221. PubMed ID: 37867123
[TBL] [Abstract][Full Text] [Related]
2. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
[TBL] [Abstract][Full Text] [Related]
3. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
4. Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery.
Geoffrion D; Koenekoop RK; Harissi-Dagher M
Acta Ophthalmol; 2022 Dec; 100 Suppl 274():3-17. PubMed ID: 36482042
[TBL] [Abstract][Full Text] [Related]
5. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
[TBL] [Abstract][Full Text] [Related]
6. Glaucoma after penetrating keratoplasty and keratoprosthesis.
Khair D; El-Khoury J; Thompson P; Racine L; Harissi-Dagher M
J Fr Ophtalmol; 2024 Mar; 47(3):104023. PubMed ID: 37973521
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of the MICOF keratoprosthesis surgery.
Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
[TBL] [Abstract][Full Text] [Related]
8. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
9. Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.
El-Khoury J; Khair D; Daoud R; Thompson P; Racine L; Harissi-Dagher M
Eye (Lond); 2023 Feb; 37(3):486-491. PubMed ID: 35169272
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.
Nayman T; Bostan C; Szigiato AA; Harissi-Dagher M
Br J Ophthalmol; 2022 Jul; 106(7):935-940. PubMed ID: 33622700
[TBL] [Abstract][Full Text] [Related]
11. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
[TBL] [Abstract][Full Text] [Related]
12. Boston Keratoprosthesis Outcomes in Severe Ocular Chemical Burns in Southern China: A Retrospective Study.
Gu J; Zhai J; Zhou S; Chen J
Adv Ther; 2016 May; 33(5):760-73. PubMed ID: 27126407
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
Geoffrion D; Harissi-Dagher M
Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
[TBL] [Abstract][Full Text] [Related]
14. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
Sejpal K; Yu F; Aldave AJ
Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of Boston keratoprosthesis type I: the Chinese People's Liberation Army General Hospital experience.
Wang LQ; Wu TY; Chen XN; Xu ZQ; Yang M; Xiang R; Ma X; Zhang S; Huang YF
Br J Ophthalmol; 2022 Jun; 106(6):781-785. PubMed ID: 33674425
[TBL] [Abstract][Full Text] [Related]
16. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
[TBL] [Abstract][Full Text] [Related]
17. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience.
Pujari S; Siddique SS; Dohlman CH; Chodosh J
Cornea; 2011 Dec; 30(12):1298-303. PubMed ID: 21963861
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
Geoffrion D; Hassanaly SI; Marchand M; Daoud R; Agoumi Y; Harissi-Dagher M
Am J Ophthalmol; 2022 Mar; 235():249-257. PubMed ID: 34543660
[TBL] [Abstract][Full Text] [Related]
19. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
Shah KJ; Cheung AY; Holland EJ
Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
[TBL] [Abstract][Full Text] [Related]
20. [The Boston keratoprosthesis in the management of corneal blindness: Indications and limitations].
Stolowy N; Callet M; Beylerian M; Hoffart L; Yin GHW
J Fr Ophtalmol; 2018 Sep; 41(7):642-649. PubMed ID: 30170706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
